Research Fellowship Program
Research Fellowship Program supports early-career researchers worldwide with basic, translational, and clinical bile duct cancer research to improve patient outcomes and advance progress toward a cure.
Browse similar grants
Funder: Cholangiocarcinoma Foundation
Due Dates: September 18, 2026 (LOI portal opens) | October 9, 2026 (LOI deadline) | November 20, 2026 (LOI decision) | January 4, 2027 (Invited full application)
Funding Amounts: Up to $75,000 for one year (June 1, 2027–May 31, 2028)
Summary: Supports early-career researchers worldwide conducting basic, translational, or clinical cholangiocarcinoma research to improve patient outcomes and accelerate progress toward a cure.
Key Information: Applicants must be postdoctoral or clinical fellows without faculty positions at application and have an institutional sponsoring mentor.
Description
Established in 2015, the Cholangiocarcinoma Foundation’s Research Fellowship Program supports early-career researchers worldwide studying cholangiocarcinoma (bile duct cancer). It funds innovative basic, translational, and clinical research to improve understanding of this complex disease and accelerate progress toward a cure. Supported work includes laboratory-based models without patient clinical data, human samples or sample-derived data annotated with clinical outcomes, and studies of patient outcomes, including population and epidemiology research.
The program emphasizes research that can affect patient outcomes through hypothesis-driven aims, well-designed analyses, and statistical rigor. CCF also seeks to foster working relationships among researchers, institutions, and industry, encouraging the sharing of information, samples, and expertise. Prior experience in cholangiocarcinoma research is not required.
